3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
about
Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015).Toward an Understanding of Structural Insights of Xanthine and Aldehyde Oxidases: An Overview of their Inhibitors and Role in Various Diseases.Screening inhibitors of xanthine oxidase from natural products using enzyme immobilized magnetic beads by high-performance liquid chromatography coupled with tandem mass spectrometry.Design, synthesis, and biological evaluation of 5-(4-(pyridin-4-yl)-1H-1,2,3-triazol-1-yl)benzonitrile derivatives as xanthine oxidase inhibitors.The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function.
P2860
Q37127097-0738BDDC-EE97-48B8-9A2A-9D34FACC95C8Q37641297-9A2D75C4-7B9B-42CC-81D8-E0D749809EE8Q39007529-80BA00E0-50D7-45CC-A254-B497029AD5D0Q39411224-98418245-AA3D-49BF-AD80-565FD901FC48Q48162666-BAD50CAC-F443-4713-A5C9-FBC2A1E3313EQ48285815-197F5EB5-FAF9-4BAF-A278-17C819762667Q50086018-29540004-2699-462D-A0C2-F91F8108FD53
P2860
3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
3,4-Dihydroxy-5-nitrobenzaldeh ...... ent of hyperuricemia and gout.
@en
3,4-Dihydroxy-5-nitrobenzaldeh ...... ent of hyperuricemia and gout.
@nl
type
label
3,4-Dihydroxy-5-nitrobenzaldeh ...... ent of hyperuricemia and gout.
@en
3,4-Dihydroxy-5-nitrobenzaldeh ...... ent of hyperuricemia and gout.
@nl
prefLabel
3,4-Dihydroxy-5-nitrobenzaldeh ...... ent of hyperuricemia and gout.
@en
3,4-Dihydroxy-5-nitrobenzaldeh ...... ent of hyperuricemia and gout.
@nl
P2093
P2860
P1476
3,4-Dihydroxy-5-nitrobenzaldeh ...... ent of hyperuricemia and gout.
@en
P2093
Changyi Chen
Jian-Ming Lü
P2860
P304
P356
10.1016/J.BCP.2013.08.011
P407
P577
2013-08-30T00:00:00Z